Executive Director, Winton Centre for Risk and Evidence Communication
Publications
Do colored cells in risk matrices affect decision-making and risk perception? Insights from randomized controlled studies.
– Risk Analysis
(2023)
(doi: 10.1111/risa.14091)
The effects of communicating scientific uncertainty on trust and decision making in a public health context
– Judgment and Decision Making
(2023)
17,
849
(doi: 10.1017/s1930297500008962)
Transparent communication of evidence does not undermine public trust in evidence
– PNAS Nexus
(2022)
1,
pgac280
(doi: 10.1093/pnasnexus/pgac280)
Investigating the presentation of uncertainty in an icon array: A randomized trial.
– PEC Innov
(2022)
1,
None
(doi: 10.1016/j.pecinn.2021.100003)
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis
– PLOS ONE
(2022)
17,
e0275321
(doi: 10.1371/journal.pone.0275321)
The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis.
– PloS one
(2022)
17,
e0275321
(doi: 10.1371/journal.pone.0275321)
COVID-19 risk perception and hoax beliefs in the US immediately before and after the announcement of President Trump's diagnosis
– Royal Society Open Science
(2022)
(doi: 10.1098/rsos.212013.)
COVID-19 risk perception and hoax beliefs in the US immediately before and after the announcement of President Trump's diagnosis.
– Royal Society open science
(2022)
9,
212013
(doi: 10.1098/rsos.212013)
Making BRCA1 genetic test reports easier to understand through user-centered design: A randomized trial
– Genetics in Medicine
(2022)
24,
1684
(doi: 10.1016/j.gim.2022.04.016)
The effects of President Trump’s COVID-19 diagnosis on hoax beliefs and risk perceptions of the virus in the U.S.
(2021)
(doi: 10.31234/osf.io/frxt8)
- 1 of 6